Helen Blair Simpson, MD, PhD
- 14Articles
- 62KReads
- 2006–2018Active
- 55Collaborators
- 551Citations
About
Helen Blair Simpson, MD, PhD, has published extensively on obsessive-compulsive and related disorders, focusing on pharmacological and behavioral treatment approaches. Her work includes studies on the effects of novel agents such as rapastinel, ketamine, memantine, and minocycline, as well as investigations into cognitive-behavioral therapy and exposure and response prevention strategies. Between 2006 and 2018, she contributed to clinical trials and open-label studies assessing treatment response, patient adherence, and long-term outcomes in obsessive-compulsive disorder. Her frequent collaborators include Carolyn I. Rodriguez, Edna B. Foa, Jordana Zwerling, Carmen P. McLean, and Donna Vermes.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
